The issue examines the key challenges involved in ensuring competitive pharmaceutical markets, including pricing practices, patent strategies, barriers to market entry, regulatory interactions, and the need to strike a balance between fostering innovation and ensuring access to medicines.

Featuring contributions from RCC members and external experts, this issue provides a comprehensive overview of recent developments, enforcement priorities, and analytical approaches in pharmaceutical competition law. The articles highlight the complexity of the sector and the importance of combining legal analysis with economic and sector-specific expertise when addressing competition concerns. The issue also features insights from the Antimonopoly Regulation Service of the Ministry of Economy and Commerce of the Kyrgyz Republic, presenting recent developments and experiences from its jurisdiction.

By bringing together a diverse range of perspectives and expertise, this edition contributes to the ongoing discussion on how competition policy can promote innovative, efficient and accessible pharmaceutical markets. It reflects the RCC’s continued commitment to knowledge-sharing, dialogue and cooperation among competition authorities in addressing the challenges of rapidly evolving markets.